Last reviewed · How we verify

NCT04158167

Neurobiological Effects of Oxytocin in Schizophrenia - Imaging Study

Completed NA Last updated 8 November 2019
What this trial tests

NA trial testing oxytocin in Schizophrenia in 90 participants. Completed in 30 December 2018.

Timeline
1 September 2013
Primary endpoint
30 December 2018
30 December 2018

Quick facts

Lead sponsorNational Institute of Mental Health and Neuro Sciences, India
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment90
Start date1 September 2013
Primary completion30 December 2018
Estimated completion30 December 2018
Sites1 location across India

Drugs / interventions tested

Conditions studied

Sponsor

National Institute of Mental Health and Neuro Sciences, India

Who can join

Adults 18 to 50, male only, with Schizophrenia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

To investigate whether 24IU oxytocin can result in changes in functional brain connectivity in patients with schizophrenia and healthy individuals using functional magnetic resonance imaging (fMRI). The study will also examine the effect of oxytocin receptor gene polymorphism on the functional connectivity

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Pituitary crosstalk with bone, adipose tissue and brain.
    Zaidi M, Yuen T, Kim SM. · · 2023 · cited 31× · PMID 37715028 · DOI 10.1038/s41574-023-00894-5

Verify or expand the search:

Other trials of oxytocin

Trials testing the same drug.

Other recruiting trials for Schizophrenia

Currently open trials in the same condition.

Other National Institute of Mental Health and Neuro Sciences, India trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04158167.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing